Detalhe da pesquisa
1.
Prognostic markers for colorectal cancer: estimating ploidy and stroma.
Ann Oncol
; 29(3): 616-623, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29293881
2.
Variation in the availability of cancer drug generics in the United States of America.
Ann Oncol
; 24 Suppl 5: v17-22, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23975700
3.
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
Ann Oncol
; 24(1): 179-85, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22865778
4.
The TERT variant rs2736100 is associated with colorectal cancer risk.
Br J Cancer
; 107(6): 1001-8, 2012 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878375
5.
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22.
Br J Cancer
; 105(6): 870-5, 2011 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21811255
6.
Cancer in Africa: supporting advocates to stop the runaway train.
Ann Oncol
; 24(4): 855-6, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515401
7.
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan.
Ann Oncol
; 18(12): 2025-9, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17846021
8.
Standard operating procedure for the collection of fresh frozen tissue samples.
Eur J Cancer
; 43(5): 828-34, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17329097
9.
Better value cancer care for the 21st century.
Ann Oncol
; 22(12): 2541-2545, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052989
10.
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme.
J Natl Cancer Inst
; 84(7): 494-500, 1992 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-1545439
11.
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.
Cancer Res
; 56(9): 2178-84, 1996 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8616869
12.
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.
Cancer Res
; 53(3): 523-7, 1993 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8093854
13.
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice.
Cancer Res
; 49(13): 3587-93, 1989 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2731178
14.
Phase I and pharmacokinetic study of flavone acetic acid.
Cancer Res
; 47(24 Pt 1): 6776-81, 1987 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-3677106
15.
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester).
Cancer Res
; 46(6): 3142-6, 1986 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-3698028
16.
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
Oncogene
; 11(7): 1217-28, 1995 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-7478541
17.
CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
Oncogene
; 13(10): 2243-54, 1996 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-8950992
18.
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridin.
Biochim Biophys Acta
; 1362(1): 29-38, 1997 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-9434097
19.
Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
Cell Death Differ
; 9(3): 287-300, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11859411
20.
Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.
J Clin Oncol
; 16(8): 2761-9, 1998 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9704729